PARSIPPANY, N.J., Dec. 13, 2023 /PRNewswire/ -- Sytheon is thrilled to announce that its new turnkey product for treating Atopic Dermatitis (eczema) has further patent protection – and is actively seeking an exclusive partner to bring it to the OTC dermatological market.
The Therapeutic Goods Administration (TGA) has been notified of shortages of Imdur Durules and Monodur Durules isosorbide mononitrate 120 mg modified release tablets. The shortages are expected to continue until 19 December 2022.